Plasmacytoma: A Rare Case of Bone Malignancy
DOI:
https://doi.org/10.5281/zenodo.6857825Keywords:
Plasmacytoma, Histopathology, Plasma cellAbstract
Solitary Plasmacytoma is a rare disease characterized by a localized proliferation of neoplastic monoclonal plasma cell, without evidence of systemic disease. It can be subdivided into solitary bone plasmacytoma if the lesion originates in bone, or solitary extramedullary plasmacytoma if the lesion involves a soft tissue. A 25-year-old male patient is admitted to our clinic with hip pain. In the biopsy performed from the left iliac bone, atypical cells with rounded nuclei, granular chromatin and eccentrically located, extensive cytoplasm, and plasma cell morphology were observed. Because of CD38 positivity and plasma cell morphology, kappa lambda examination performed by CISH showed kappa positive lambda negative. Plasmocytomas are easily recognizable on tissue sections if the plasma cells are not poorly differentiated (plasmoblastic or anaplastic). In poorly differentiated lesions, immunohistochemical staining or in situ hybridization studies of kappa and lambda light chains can be performed.
References
Caers J., Paiva B., Zamagni E., et al. Diagnosis, treatment, and response assessment in solitary plasmacytoma: updated recommendations from a European expert panel. Journal of Hematology & Oncology . 2018;11(1) doi: https://doi.org/10.1186/s13045-017-0549-1
Thumallapally N., Meshref A., Mousa M., Terjanian T. Solitary plasmacytoma: population-based analysis of survival trends and effect of various treatment modalities in the USA. BMC Cancer . 2017;17(1):p. 13. doi: https://doi.org/10.1186/s12885-016-3015-5
Weberpals J., Pulte D., Jansen L., et al. Survival of patients with lymphoplasmacytic lymphoma and solitary plasmacytoma in Germany and the United States of America in the early 21st century. Haematologica. 2017;102(6):e229–e232. doi: https://doi.org/10.3324/haematol.2016.157768
International Myeloma Working G. Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group. British Journal of Haematology . 2003;121(5):749–757. doi: https://doi.org/10.1046/j.13652141.2003.04355.x
Grammatico, S., Scalzulli, E., & Petrucci, M. T. (2017). Solitary Plasmacytoma. Mediterranean journal of hematology and infectious diseases, 9(1), e2017052. https://doi.org/10.4084/MJHID.2017.052
Zhou, T., Cheng, J., Karrs, J., Davies-Hill, T., Pack, S. D., Xi, L., Tyagi, M., Kim, J., Jaffe, E. S., Raffeld, M., & Pittaluga, S. (2022). Clinicopathologic and Molecular Characterization of Epstein-Barr Virus-positive Plasmacytoma. The American journal of surgical pathology, 10.1097/PAS.0000000000001923. Advance online publication. https://doi.org/10.1097/PAS.0000000000001923
WHO Classification of Tumors Revised 4th Edition, Volume 2.
Mendenhall, W. M., Mendenhall, C. M., & Mendenhall, N. P. (2003). Solitary plasmacytoma of bone and soft tissues. American journal of otolaryngology, 24(6), 395–399. https://doi.org/10.1016/s0196-0709(03)00092-9
Steinberg Diagnostic Surgical Pathology , 6th Edition, Volume 2
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Journal of Clinical Trials and Experimental Investigations
This work is licensed under a Creative Commons Attribution 4.0 International License.
The journal is licensed under a Attribution4.0 International (CC BY 4.0).